Successfully completed dozens of behavioral health and specialty healthcare M&A transactions ranging from $1 million to $1.2 billion in transaction value as buy-side, sell-side and/or due diligence counsel. Representative matters include:

• Represented Levine Leichtman Capital Partners in its investment in SEV, a market-leading manager and operator of med spas that provide medical aesthetic services across the US.
• Represented Monte Nido & Affiliates, a leading national eating disorder treatment provider, in its sale to Revelstoke Capital Partners. Behavioral Health Business named this transaction a 2022 Deal that Defined Behavioral Health Investment.
• Represented Hightop Health, a PE-sponsored outpatient mental health treatment provider in its investment in Roots Behavioral Health, a leading psychiatry and ketamine-assisted treatment provider in Texas, and its investment in Georgia Psychiatry and Sleep, a leading provider in Georgia, as part of a national roll-up strategy.
• Represented PE-sponsored national residential and outpatient addiction treatment provider in 18 add-on acquisition transactions involving outpatient opioid addiction treatment programs in nine states.
• Represented PE-sponsored national outpatient addiction treatment provider in 12 add-on acquisition transactions involving opioid addiction and mental health treatment programs in five states.
• Represented PE-sponsored addiction, mental health and eating disorder treatment provider in nine add-on acquisition transactions involving hospital-based, mental health and addiction treatment providers in six states.
• Represented Pathways Recovery Centers, a multi-state provider of drug and alcohol addiction treatment, in its acquisition of Serenity Park Recovery Center, an Arkansas addiction treatment facility, and its acquisition of Sunflower Recovery Center, a Kansas addiction treatment facility.
• Represented Paramount Health Management in acquisition of Life Launch Centers, a group of outpatient mental health counseling and PHP and IOP treatment programs in Utah.
• Represented Opya, a leading multidisciplinary early intervention autism therapy provider in California, in its acquisition of the Center for Autism Spectrum Therapy (CAST).
• Represented Nexus Group, a multi-state outpatient mental health provider in its sale to Beacon Behavioral Partners, a PE-sponsored national behavioral health treatment provider.
• Represented Mahajan Therapeutics, a leading Ohio mental health and substance abuse treatment provider, in its sale to Baymark Health Services.
• Represented Harmony Recovery Group, operator of 10 addiction treatment facilities in Florida, North Carolina, Tennessee, New Jersey and Massachusetts, in its sale to Thrive Healthcare.
• Represented Discovery Point Retreat, a multi-site eating disorder and substance abuse treatment provider in Texas in recapitalization transaction with Eagle Capital Health Ventures.
• Represented Acacia Psychology, a leading regional provider of collegiate mental health in California and Minnesota, in its sale to MindPath Health.
• Represented investor group in acquisition of distressed multi-state addiction treatment provider with operations in California, Tennessee and Texas.
• Represented PE-sponsored addiction and mental health treatment provider in multiple add-on acquisitions of outpatient treatment programs in Tennessee, Ohio and Texas.
• Represented investor group in acquisition of distressed multi-state addiction treatment provider with operations in California, Tennessee and Texas.
• Represented family office investor in multiple acquisitions of behavioral health treatment programs in Florida, Georgia, New Jersey and New York.
• Represented PE-sponsored national eating disorder treatment provider in acquisition of a group of California eating disorder treatment programs.
• Represented real estate investment fund in sale-leaseback of behavioral health facilities in Michigan, Ohio, Tennessee, Texas and Virginia.
• Represented real estate investment fund in multi-state lease restructuring and retenanting transaction involving a distressed national behavioral health provider.
• Represented investor group in acquisition of residential and outpatient substance abuse treatment business in Hawaii.
• Represented seller and management team in private equity recapitalization transaction involving multi-site behavioral health provider.
• Represented non-profit behavioral health provider in sale to PE-sponsored behavioral health portfolio company.
• Represented non-profit behavioral health provider in affiliation with national nonprofit behavioral health provider.
• Provided regulatory, reimbursement, transaction support for development of de novo treatment sites across the US, telehealth, health technology, medical device and technology-assisted substance abuse and eating disorder treatment programs.